Venture Life has reported interim results for the 6-months to June 2025 (1H25), which will contribute to the new, May year-end, 17-month period to May 2026 (FY26). Revenues of £15.4m were up 43%, supported by the acquisition of Health & Her (H&H), and 12% on a proforma basis. Adjusted EBITDA increased to £1.8m from £1.4m, though the EBITDA margin declined, as the company increased its investment in brand marketing and support. Net debt at the close was £20.7m, which moved to a net cash position ....
